DMARDs & Reduced Risk -> #longgame Model System https://t.co/DSRGKEFvX2
Re. more refined analysis of immunomodulators For example: https://t.co/DSRGKEFvX2 (However, in this study, PD served as ND exclusion criteria, therefore risk of PD was not evaluated)... super interesting however, as control #LongGame [reduced risk of ND].
“Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis. - PubMed - NCBI” https://t.co/4uGVjHUi6o
@HHakeam الدراسة خلصت إلى أن Enbrel قد يستخدم مستقبلاً لعلاج الإلزهايمرإذا ما أثبتت الدراسات السريرية ذلك مستقبلاً! https://t.co/VNscQr17Kt (8)
@corruptBulgaria @newstart43 @mmencherogarcia @pfizer @washingtonpost Further, in other published studies on the effects of Enbrel on AD risk in RA patients, only Enbrel, and not other anti-TNF therapies like Humira, showed possible effects on the AD risk
実際、ファイザーの研究ではないが、保険請求データの分析から、エタネルセプトがアルツハイマー病リスク低下と関連があること自体は報告されている。 https://t.co/l7C17pN9br
Sources: https://t.co/NrwEUbAWQj and https://t.co/5tKeZU5DLB
"If you are curious about what insurance claim data show about RA, Alzheimer’s and treatment with Enbrel, let me refer you to [https://t.co/hMiV9tgrJa] https://t.co/r01xywR77L" by @Dereklowe.
RT @CaloriesProper: Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis https://t.co/6j2VeM4…
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis https://t.co/6j2VeM4ebh
RT @radioramin: @girlsreallyrule Not quite true - an academic group from Dartmouth published the insurance database findings in 2016. Full…
@girlsreallyrule Not quite true - an academic group from Dartmouth published the insurance database findings in 2016. Full paper linked here. Also, group in UK already completed small randomized phase II study in 41 patients. https://t.co/TVP8xym3CO https:
@nihalsatyadev @pfizer Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@prodigypoint Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@Lynestel @smh Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@Dereklowe @nedclark @peterbachmd @adamfeuerstein @John_LaMattina Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@adamfeuerstein @peterbachmd @John_LaMattina @matthewherper Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@girlsreallyrule Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016. Available to all.
@Acute_Tweetment It’s not a treatment. Maybe it prevents Alzheimer’s disease. Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016. Not even hidden.
@KnouseMike @nypost Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@JeffTeravainen Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@jesusanampa @washingtonpost Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@DrHaigentz Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@MaryCushmanMD @pfizer Here’s a similar analysis of insurance data across the anti TNF class. Published and even in PMC. https://t.co/0uoTYYsERI From November 2016.
@pinkbirdgirl Others did the analysis across the anti TNF class and published it https://t.co/0uoTYYsERI so it’s out there.
Others did the analysis across the anti-TNF class and published it. Here: https://t.co/0uoTYYsERI
@ers_net It was done across the class https://t.co/0uoTYYsERI . What’s odd is it would seem like one should be able to look at older patients on anti TNFs for other indications as other informative populations.
@WvSchaik A quick PubMed search reveals 27 papers on etanercept (Enbrel) going back 12 years. Typical is this one: https://t.co/KQxZXMMCZ4 People with RA are at increased risk of AD and etanercept reduces it. It also seems to be commonly prescribed for RA
@DrADKline @adamfeuerstein @John_LaMattina @peterbachmd That was just a small safety study, the more relevant paper is here, which is basically a bigger/better version of the study WaPo claims that Pfizer/Amgen was hiding https://t.co/I29C5AbJYT
RT @JohnNosta: The @washingtonpost reports that Pfizer suppressed early evidence that Embrel could prevent #Alzheimer's. Yet, there seems…
@elandhuis Let me amend my criticism: this association was published, which somebody else (@radioramin) pointed out https://t.co/vzvaOoj81J
RT @JohnNosta: The @washingtonpost reports that Pfizer suppressed early evidence that Embrel could prevent #Alzheimer's. Yet, there seems…
The @washingtonpost reports that Pfizer suppressed early evidence that Embrel could prevent #Alzheimer's. Yet, there seems to be published data on this. Comments? https://t.co/TDMa5mHKIO @akalali @roncohenshair
@RESachs Also this, a retrospective claims-based analysis published in 2016 showing that Enbrel was associated with significantly reduced risk of Alzheimer's https://t.co/YT1CeTuHN4 https://t.co/26w7361RUU
@skathire @DonnaYoungDC @pfizer Also, the data is public & fully published by a group at Dartmouth! https://t.co/ekFE2NdZDq Nothing is stopping NIH or consortium of neurologists from organizing a trial on their own.
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis https://t.co/fjTvy7dDry
Before we grab our pitchforks over the Enbrel story, let’s note a couple of things: 1. a smaller trial was inconclusive, so Enbrel certainly isn’t a miracle cure. 2. Buried in the article is this report from 2016. Enbrel’s effects have been known. https:
@pashulman @nycsouthpaw Nah. There was already a small trial that proved inconclusive so this isn’t a magic bullet. Plus, their insurance data study wasn’t even the largest one. This 2016 paper reported basically the same things. https://t.co/kxGbO03JGK
@nycsouthpaw The potential for anti-tnf agents to prevent AD is publicly available information, and applies to all of the anti-TNF class https://t.co/GstBq6jyzs .
Aware of these - was more frustrated that Pfizer could have done more on this and what could have been a missed opportunity in providing helpful data to put more pieces of the Alzheimer's jigsaw on the table to help build the picture we all still seek! Gre
@ProfPatKehoe There have been publications https://t.co/2UPswxcwgC We’re funding data studies as well as a prospective study in Patients with RA and MCI
The potential for anti-tnf agents to prevent AD is publicly available information, and applies to all of the anti-TNF class https://t.co/GstBq6jyzs .
関節リウマチの人はアルツハイマー病のリスクが高いが、エタネルセプトを服用しているとリスクが低い。Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: https://t.co/Lbh7bF1T8b
RT @IlindelatorreMD: Terapia con anti-TNF (Etanercept) en Artritis Reumatoidea reduce riesgo de Enf. de Alzheimer. SpringerLink https://t.…
RT @IlindelatorreMD: Terapia con anti-TNF (Etanercept) en Artritis Reumatoidea reduce riesgo de Enf. de Alzheimer. SpringerLink https://t.…
RT @IlindelatorreMD: Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis | SpringerLink http…
RT @IlindelatorreMD: Terapia con anti-TNF (Etanercept) en Artritis Reumatoidea reduce riesgo de Enf. de Alzheimer. SpringerLink https://t.…
RT @IlindelatorreMD: Terapia con anti-TNF (Etanercept) en Artritis Reumatoidea reduce riesgo de Enf. de Alzheimer. SpringerLink https://t.…
Terapia con anti-TNF (Etanercept) en Artritis Reumatoidea reduce riesgo de Enf. de Alzheimer. SpringerLink https://t.co/uzBt9H5NQd
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis | SpringerLink https://t.co/uzBt9H5NQd
RT @NeurologyToday: CNS Drugs: Etanercept, a drug used to treat rheumatoid arthritis, may help protect against #Alzheimers: https://t.co/D8…
RT @NeurologyToday: CNS Drugs: Etanercept, a drug used to treat rheumatoid arthritis, may help protect against #Alzheimers: https://t.co/D8…
RT @NeurologyToday: CNS Drugs: Etanercept, a drug used to treat rheumatoid arthritis, may help protect against #Alzheimers: https://t.co/D8…
CNS Drugs: Etanercept, a drug used to treat rheumatoid arthritis, may help protect against #Alzheimers: https://t.co/D8eXxmM1to
Embargoed Press Release[1] from the INR PLLC Re: Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for... https://t.co/wWkbxtFwAn
Embargoed Press Release[1] from the INR PLLC Re: Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for... https://t.co/DsF0huERtd
Embargoed Press Release[1] from the INR PLLC Re: Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for... https://t.co/Uc5fYeOv6C
Embargoed Press Release[1] from the INR PLLC Re: Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for... https://t.co/1W4GNnM90K
Exposure to etanercept was associated with lowered risk of AD among RA pts (aOR=0.30; 0.08–0.89) https://t.co/YgEIUEj3ul
Relative risk of AD among RA subjects was lowered in those using anti-TNF Rx etanercept ? Hope as an Rx for AD https://t.co/C9Co0CERQG
PubMed: Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis. https://t.co/qXlQvzMEuI